- $106.31m
- $86.28m
- $19.61m
Brief: iCAD, Inc. Q1 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Cognex, Equifax, Netflix
RadNet falls after $103 million all-stock acquisition to buy iCAD
Icad Inc Reports Results For The Quarter Ended December 31: Earnings Summary
Icad Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
Icad Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
Icad Inc Reports Results For The Quarter Ended September 30: Earnings Summary
Brief: iCAD, Inc. Q3 Gross Profit USD 3.6 Million
Brief: ICAD's Profound Detection Version 4.0 Gains FDA Clearance
Icad Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview
Icad Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: iCAD, Inc. Q2 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Brief: iCAD, Inc. Q1 Gross Profit USD 4.1 Million
Icad Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: iCAD, Inc. Q4 Gross Profit USD 4.3 Million
Icad Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview
Brief: iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024